Systematic Analysis of Drug Targets Confirms Expression in Disease-Relevant Tissues

Vinod Kumar1, Philippe Sanseau2, Daniel F Simola1

  • 1Computational Biology, GlaxoSmithKline, 709 Swedeland Road, King of Prussia, PA 19406, USA.

Scientific Reports
|November 9, 2016
PubMed

Insights

Most drug targets are expressed in relevant tissues under normal conditions, validating the importance of tissue-specific expression for drug development. This study confirms expression patterns for numerous gene-disease pairs.

Area of Science:

  • Pharmacology
  • Genomics
  • Biomedical Research

Background:

  • It is widely assumed that drug targets are expressed in tissues relevant to their indicated diseases under normal physiological conditions.
  • While anecdotal evidence exists, a comprehensive analysis to verify this assumption across numerous drug targets has been lacking.

Purpose of the Study:

  • To systematically analyze gene and protein expression of drug targets in normal human tissues.
  • To validate the hypothesis that drug targets are expressed in disease-relevant tissues under healthy conditions.

Main Methods:

  • Conducted a systematic analysis of gene and protein expression data.
  • Examined targets for marketed and Phase III drugs.
  • Utilized a diverse collection of normal human tissues.

Main Results:

  • 87% of gene-disease pairs showed target expression in disease-affected tissues under normal conditions.
  • This finding supports the necessity of confirming target expression in relevant tissues for new drug indications.
  • The remaining 13% of gene-disease pairs indicated expression in tissues linked to other diseases.

Conclusions:

  • The study validates the critical role of tissue-specific expression of drug targets in relevant tissues under normal conditions.
  • Confirms the importance of comprehensive expression analysis for drug target validation.
  • Highlights the utility of extensive tissue-specific expression datasets for drug discovery and development.

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
61
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.9K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
61
Tissue-Drug Binding: Localization of Drugs and its Significance01:24

Tissue-Drug Binding: Localization of Drugs and its Significance

Body tissues, comprising approximately 40% of the body weight, are crucial in drug distribution and localization. These tissues can serve as drug storage sites, competing with plasma binding sites for drug molecules.
Drugs can bind to different tissue components, enhancing their distribution and localization. The factors influencing drug localization in tissues include the drug's lipophilicity, structural characteristics, tissue perfusion rate, and pH differences. These factors determine...
521